Lnbloc 20 Tablet contains Cilnidipine 20mg, a dihydropyridine calcium channel blocker primarily indicated for the management of hypertension. Cilnidipine exerts its antihypertensive effect by selectively inhibiting L-type and N-type calcium channels, resulting in vasodilation of peripheral arteries and reduction of sympathetic nervous system activity. This dual mechanism leads to decreased peripheral vascular resistance and lowered blood pressure, thereby reducing the risk of cardiovascular complications associated with hypertension. Lnbloc 20 is effective in controlling both systolic and diastolic blood pressure and may also provide renal protective benefits by reducing glomerular hypertension. The tablet is typically administered once daily, with or without food, as prescribed by a healthcare professional. Common adverse effects may include dizziness, headache, flushing, and peripheral edema, although these are generally mild and transient. Lnbloc 20 should be used cautiously in patients with severe hypotension, hepatic impairment, or known hypersensitivity to cilnidipine or other calcium channel blockers. Regular monitoring of blood pressure and renal function is recommended during therapy. Lnbloc 20 offers a valuable therapeutic option for patients requiring effective and well-tolerated antihypertensive treatment to achieve optimal blood pressure control and reduce cardiovascular risk.